سعر بيجاسيس 180 مكجم/مل سرنجة معبأة مسبقاً 2022

Pegasys peginterferon alfa-2a 180 mcg prefilled syringe for subcutaneous injection, 1 syringe (F. Hoffmann-La Roche; distributed in Egypt by Multipharma).

• Chronic hepatitis B (HBeAg-positive or negative) in adults with compensated liver disease; HBeAg-positive CHB in children 3 years and olderPopulation: Adults and children >=3 yearsEuropean Medicines Agency
• Chronic hepatitis C in combination with other medicines (adults; children 5 years and older with ribavirin)Population: Adults and children >=5 yearsEuropean Medicines Agency
• Polycythaemia vera and essential thrombocythaemia (monotherapy, adults)Population: AdultsEuropean Medicines Agency

• Very common: loss of appetite, depression, anxiety, headache, insomnia, dizziness, cough, dyspnoea, fever, diarrhoea, nausea, abdominal pain, rash, itching, hair loss, muscle and joint pain, injection-site reactions, tiredness.International label, same formulation · European Medicines Agency

• Must not be used together with telbivudine, in patients with uncontrolled thyroid disease, certain liver, heart or autoimmune conditions, or in neonates and children under 3 years (contains benzyl alcohol).International label, same formulation · European Medicines Agency

• Severe psychiatric effects (depression, suicidal thoughts and attempts) may occur during and after treatment; all patients should be monitored. May slow growth in children.International label, same formulation · European Medicines Agency

• TelbivudineCombination with telbivudine is contraindicated.European Medicines Agency

• Peginterferon alfa-2a: Alfa interferon acting as an immunomodulator and inhibiting viral replication; pegylation slows its clearance, allowing weekly dosing.